ELI LILLY & Co — Director's Dealing 2019

Feb 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2019-02-04

Reporting Person: Conterno Enrique A (SVP&Pres, LillyDiab & LillyUSA)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-04	Common Stock	A	26681	$120.17	Acquired	157961	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-04	Restricted Stock Unit	$	A	20397	Acquired	2020-02-01	Common Stock (20397.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5159	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.